ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) Declines 0.36% to HK$13.700

NewTimeSpace News, according to the latest data from the HKEX, as of 13:43 on May 26, the ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) lost 0.36% to trade at HK$13.700. The intraday high was HK$13.800 and the low was HK$13.440, with an average price of HK$13.634. The total AUM is approximately HK$2.134 billion, with the latest Net Asset Value (NAV) per unit at HK$13.750, representing a discount of -0.09%.

The ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) tracks the Hang Seng Hong Kong Listed Biotech Index, the authoritative benchmark specifically measuring the overall performance of biotechnology companies listed in Hong Kong. Its constituents are primarily selected from leading enterprises in innovative drugs, biotechnology, medical devices, and life sciences listed under Chapter 18A of the Listing Rules.

By setting market capitalization and liquidity thresholds, the index provides a concentrated reflection of core asset performance in Hong Kong—a global hub for biotech financing. It offers investors a professional allocation tool to capture the dividends of medical technology innovation and the high growth potential of the biopharmaceutical sector.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.